Certain hormonal contraceptives are associated with a higher stroke and heart attack risk, finds a large study from Denmark in The BMJ today that draws on prescription records to give more precise ...

Insurance Corporation has expanded its benefit packages for heart disease treatments, easing patients’ financial burdens and ensuring timely access to critical medical procedures. Janette Manaois, ...

Data suggest a dose-related association between progestin-only products and arterial thrombotic risk. Various hormonal contraceptives were linked to incident cardiovascular disease in an analysis of ...

Certain hormonal contraceptives are associated with a higher stroke and heart attack risk, finds a large study from Denmark ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those who ...

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of ...

The key to treating congestive heart failure is addressing the underlying causes, and treatment is highly tailored to each patient's needs. Chris Bell, an acute care nurse practitioner who specializes ...

Eleven scientists will be recognized for their individual exceptional professional achievements and contributions to stroke care and research during the American Stroke Association’s International ...